Glycyrrhizic acid induced acquired apparent mineralocorticoid excess syndrome with a hyperadrenergic state: a case report.

Autor: Szendrey J; Department of Internal Medicine, UMass Chan Medical School, Baystate Medical Center, 759 Chestnut St., Springfield, MA, 01199, USA. John.szendrey@baystatehealth.org., Poindexter A; Division of Nephrology, UMass Chan Medical School, Baystate Medical Center, 759 Chestnut St., Springfield, MA, 01199, USA., Braden G; Division of Nephrology, UMass Chan Medical School, Baystate Medical Center, 759 Chestnut St., Springfield, MA, 01199, USA.

Publikováno v: Journal of medical case reports [J Med Case Rep] 2024 Aug 07; Vol. 18 (1), pp. 358. Date of Electronic Publication: 2024 Aug 07.

Apparent mineralocorticoid excess: A diagnosis beyond classical causes of severe hypertension in a child.

Autor: Gulhan B; Division of Pediatric Nephrology, Department of Pediatrics., Ünsal Y; Division of Pediatric Endocrinology, Department of Pediatrics., Baltu D; Division of Pediatric Nephrology, Department of Pediatrics., Çelik Ertaş NB; Division of Pediatric Endocrinology, Department of Pediatrics., Özdemir G; Division of Pediatric Nephrology, Department of Pediatrics., Utine E; Division of Pediatric Genetics, Department of Pediatrics, Hacettepe University School of Medicine and  Hacettepe University School of Medicine, Department of Radiology, Ankara, Turkey., Ozcan HN; Division of Pediatric Nephrology, Department of Pediatrics., Duzova A; Division of Pediatric Nephrology, Department of Pediatrics., Gönç N; Division of Pediatric Endocrinology, Department of Pediatrics.

Publikováno v: Blood pressure monitoring [Blood Press Monit] 2022 Jun 01; Vol. 27 (3), pp. 208-211. Date of Electronic Publication: 2022 Jan 17.

Antifungal Therapy with Azoles Induced the Syndrome of Acquired Apparent Mineralocorticoid Excess: a Literature and Database Analysis.

Autor: Ji HH; Department of Pharmacy, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China., Tang XW; Chengdu Shuchuang Linyan Technology Co., Ltd, Chengdu, China., Zhang N; Department of Pharmacy, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China., Huo BN; Department of Pharmacy, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China., Liu Y; Department of Pharmacy, National Center for Children's Health, Beijing Children's Hospital, Capital Medical University, Beijing, China., Song L; Department of Pharmacy, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China., Jia YT; Department of Pharmacy, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 Jan 18; Vol. 66 (1), pp. e0166821. Date of Electronic Publication: 2021 Oct 18.

Clinical Outcomes in Patients With Refractory Anemia With Excess Blasts (RAEB) Who Receive Hypomethylating Agents (HMAs).

Autor: Zeidan AM; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT. Electronic address: amer.zeidan@yale.edu., Mearns ES; Genentech, Inc., South San Francisco, CA., Ng CD; Genentech, Inc., South San Francisco, CA., Shah A; Genentech, Inc., South San Francisco, CA., Lamarre N; Real World Data Analytics, Genesis Research, Hoboken, NJ., Yellow-Duke A; Genentech, Inc., South San Francisco, CA., Alrawashdh N; IQVIA, Falls Church, VA., Yang B; Roche Diagnostics, Santa Clara, CA., Cheng WH; AbbVie, North Chicago, IL., Bui CN; AbbVie, North Chicago, IL., Svensson A; AbbVie, North Chicago, IL.

Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Mar; Vol. 24 (3), pp. 177-186. Date of Electronic Publication: 2023 Oct 30.

Apparent mineralocorticoid excess caused by novel compound heterozygous mutations in HSD11B2 and characterized by early-onset hypertension and hypokalemia.

Autor: Fan P; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Lu YT; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Yang KQ; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Zhang D; Emergency and Critical Care Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Liu XY; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Tian T; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Luo F; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Wang LP; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Ma WJ; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Liu YX; Emergency and Critical Care Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Zhang HM; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Song L; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Cai J; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Lou Y; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. fuwailou1798@sina.com., Zhou XL; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. zhouxianliang0326@hotmail.com.

Publikováno v: Endocrine [Endocrine] 2020 Dec; Vol. 70 (3), pp. 607-615. Date of Electronic Publication: 2020 Aug 20.